An open, monocentric, uncontrolled phase 4 trial to characterise cellular and humoral immune responses following the first booster immunisation with the inactivated, purified Japanese Encephalitis vaccine IXIARO in elderly compared to young individuals.
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2018
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- 17 Jan 2018 Location has been assumed as per the source considering the sponsor to be a medical university.
- 17 Jan 2018 New trial record